Short-read Sequencing Market Size US$ 36 Billion by 2032

According to the new research report published by Precedence Research, titled “Short-read Sequencing Market (By Technology: Next-Generation Sequencing, Sanger Sequencing; By Workflow: Pre-Sequencing, Sequencing, Data Analysis; By Product: Instruments, Consumables, Services; By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics and Forensics, HLA Typing/ Immune System Monitoring; By End User)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global short-read sequencing market size is expected to be worth around US$ 36 billion by 2032 and is poised to record a yearly growth rate of 19.04% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.

This report focuses on short-read sequencing market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall short-read sequencing market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.

 The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2887

The study also provides important advancements in organic and inorganic growth strategies in the worldwide short-read sequencing market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of short-read sequencing market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.

Short-read Sequencing Market Report Scope 

Also read: Diabetes Drug Market Size US$ 118 Billion by 2032

Market Key Players

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the short-read sequencing market.

Some of the prominent players in the short-read sequencing market include

• BGI
• Agilent Technologies
• Thermo Fisher Scientific, Inc.
• ProPhase Labs, Inc. (Nebula Genomics)
• Illumina, Inc.
• Psomagen
• QIAGEN
• Azenta US, Inc. (GENEWIZ)
• PerkinElmer, Inc.
• Pacific Biosciences of California, Inc.
• Cytiva
• Fasteris SA
• Genewiz
• GenScript

Short-read Sequencing Market Segmentations 

By Technology

• Next-Generation Sequencing
• Sanger Sequencing

By Workflow

• Pre-Sequencing
• Sequencing
• Data Analysis

By Product

• Instruments
• Consumables
• Services

By Application

• Clinical Investigation
• Oncology
• Reproductive Health
• Consumer Genomics
• Agri genomics and Forensics
• HLA Typing/ Immune System Monitoring

By End User

• Academic Research
• Hospital and Clinics
• Clinical Research
• Pharmaceutical and Biotechnology Companies

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Report Objectives 

• To define, segment, and project the global market size for short-read sequencing market
• To understand the structure of the market by identifying its various sub-segments
• To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
• To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
• To profile key players and comprehensively analyse their core competencies
• To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
• To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements 

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Short-read Sequencing Market 

5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Short-read Sequencing Market, By Technology

8.1. Short-read Sequencing Market, by Technology, 2023-2032

8.1.1. Next-Generation Sequencing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Sanger Sequencing

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Short-read Sequencing Market, By Workflow

9.1. Short-read Sequencing Market, by Workflow, 2023-2032

9.1.1. Pre-Sequencing

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Sequencing

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Data Analysis

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Short-read Sequencing Market, By Product 

10.1. Short-read Sequencing Market, by Product, 2023-2032

10.1.1. Instruments

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Consumables

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Services

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Short-read Sequencing Market, By Application

11.1. Short-read Sequencing Market, by Application, 2023-2032

11.1.1. Clinical Investigation

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Reproductive Health

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Consumer Genomics

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Agri genomics and Forensics

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. HLA Typing/ Immune System Monitoring

11.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Short-read Sequencing Market, By End User

12.1. Short-read Sequencing Market, by End User, 2023-2032

12.1.1. Academic Research

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Hospital and Clinics

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Clinical Research

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Pharmaceutical and Biotechnology Companies

12.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Short-read Sequencing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End User (2020-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.5. Market Revenue and Forecast, by End User (2020-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.7. Market Revenue and Forecast, by Application (2020-2032)

13.2.8. Market Revenue and Forecast, by End User (2020-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.10. Market Revenue and Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. BGI

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Thermo Fisher Scientific, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. ProPhase Labs, Inc. (Nebula Genomics)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Illumina, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Psomagen

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. QIAGEN

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Azenta US, Inc. (GENEWIZ)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. PerkinElmer, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Pacific Biosciences of California, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global short-read sequencing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for short-read sequencing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---